These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8851651)

  • 21. Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
    Grossman R; Reynolds D; Goodman M; New A; Silverman J; Schmeidler J; Mitropoulou V; Siever LJ
    Psychiatry Res; 2004 Sep; 128(2):203-6. PubMed ID: 15488964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
    Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
    Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of venlafaxine in trichotillomania: interim phase I results.
    Ninan PT; Knight B; Kirk L; Rothbaum BO; Kelsey J; Nemeroff CB
    Psychopharmacol Bull; 1998; 34(2):221-4. PubMed ID: 9641004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venlafaxine in depressed geriatric outpatients: an open-label clinical study.
    Khan A; Rudolph R; Baumel B; Ferguson J; Ryan P; Shrivastava R
    Psychopharmacol Bull; 1995; 31(4):753-8. PubMed ID: 8851649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.
    Baldomero EB; Ubago JG; Cercós CL; Ruiloba JV; Calvo CG; López RP
    Depress Anxiety; 2005; 22(2):68-76. PubMed ID: 16094658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
    Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
    J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citalopram in the treatment of social phobia: a report of three cases.
    Lepola U; Koponen H; Leinonen E
    Pharmacopsychiatry; 1994 Sep; 27(5):186-8. PubMed ID: 7838888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open clinical trial of venlafaxine treatment of fibromyalgia.
    Dwight MM; Arnold LM; O'Brien H; Metzger R; Morris-Park E; Keck PE
    Psychosomatics; 1998; 39(1):14-7. PubMed ID: 9538670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venlafaxine withdrawal syndrome.
    Sabljić V; Ružić K; Rakun R
    Psychiatr Danub; 2011 Mar; 23(1):117-9. PubMed ID: 21448114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for social anxiety disorder: an update.
    Van Ameringen M; Mancini C; Patterson B; Simpson W
    Isr J Psychiatry Relat Sci; 2009; 46(1):53-61. PubMed ID: 19728573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venlafaxine in social phobia: a study in selective serotonin reuptake inhibitor non-responders.
    Altamura AC; Pioli R; Vitto M; Mannu P
    Int Clin Psychopharmacol; 1999 Jul; 14(4):239-45. PubMed ID: 10468317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of social phobia with benzodiazepines.
    Davidson JR; Tupler LA; Potts NL
    J Clin Psychiatry; 1994 Jun; 55 Suppl():28-32. PubMed ID: 8077166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenelzine and atenolol in social phobia.
    Liebowitz MR; Schneier F; Campeas R; Gorman J; Fyer A; Hollander E; Hatterer J; Papp L
    Psychopharmacol Bull; 1990; 26(1):123-5. PubMed ID: 2196620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
    Rickels K; Mangano R; Khan A
    J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Social phobia].
    Bandelow B; Wedekind D
    Nervenarzt; 2014 May; 85(5):635-44; quiz 645-7. PubMed ID: 24718882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venlafaxine withdrawal symptoms.
    Benazzi F
    Can J Psychiatry; 1996 Sep; 41(7):487. PubMed ID: 8884044
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.
    Stein DJ; Berk M; Els C; Emsley RA; Gittelson L; Wilson D; Oakes R; Hunter B
    S Afr Med J; 1999 Apr; 89(4):402-6. PubMed ID: 10341825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-inflammatory biomakers in depression: treatment with venlafaxine.
    Piletz JE; Halaris A; Iqbal O; Hoppensteadt D; Fareed J; Zhu H; Sinacore J; Devane CL
    World J Biol Psychiatry; 2009; 10(4):313-23. PubMed ID: 19921973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.